Insider Transactions in Q1 2024 at Annexon, Inc. (ANNX)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 20
2024
|
Michael Overdorf EVP & CHIEF BUSINESS OFFICER |
SELL
Open market or private sale
|
Direct |
1,951
-2.23%
|
$9,755
$5.48 P/Share
|
|
Feb 20
2024
|
Ted Yednock EVP & CHIEF INNOVATION OFFICER |
SELL
Open market or private sale
|
Direct |
2,604
-3.47%
|
$13,020
$5.51 P/Share
|
|
Feb 20
2024
|
Jennifer Lew EVP & CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
2,593
-3.06%
|
$12,965
$5.53 P/Share
|
|
Feb 16
2024
|
Michael Overdorf EVP & CHIEF BUSINESS OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
39,000
+30.81%
|
-
|
|
Feb 16
2024
|
Jamie Dananberg CHIEF MEDICAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
39,000
+50.0%
|
-
|
|
Feb 16
2024
|
Ted Yednock EVP & CHIEF INNOVATION OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
39,000
+34.19%
|
-
|
|
Feb 16
2024
|
Jennifer Lew EVP & CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
39,000
+31.54%
|
-
|
|
Feb 16
2024
|
Dean Richard Artis EVP & CHIEF SCIENTIFIC OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
39,000
+30.39%
|
-
|
|
Feb 12
2024
|
Douglas Love PRESIDENT AND CEO |
SELL
Open market or private sale
|
Direct |
5,782
-2.86%
|
$28,910
$5.54 P/Share
|
|
Feb 12
2024
|
Michael Overdorf EVP & CHIEF BUSINESS OFFICER |
SELL
Open market or private sale
|
Direct |
1,349
-2.7%
|
$6,745
$5.53 P/Share
|
|
Feb 12
2024
|
Ted Yednock EVP & CHIEF INNOVATION OFFICER |
SELL
Open market or private sale
|
Direct |
1,810
-4.78%
|
$9,050
$5.54 P/Share
|
|
Feb 12
2024
|
Jennifer Lew EVP & CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,809
-3.81%
|
$9,045
$5.54 P/Share
|